Vilobelimab
( DrugBank: Vilobelimab / KEGG DRUG: Vilobelimab )
3 diseases
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
43 | Microscopic polyangiitis | 4 |
44 | Wegener granulomatosis | 4 |
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
269 | Pyogenic arthritis | 2 |
43. Microscopic polyangiitis
Clinical trials : 95 / Drugs : 65 - (DrugBank : 23) / Drug target genes : 14 - Drug target pathways : 87
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
44. Wegener granulomatosis
Clinical trials : 122 / Drugs : 89 - (DrugBank : 31) / Drug target genes : 23 - Drug target pathways : 81
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
269. Pyogenic arthritis
Clinical trials : 32 / Drugs : 32 - (DrugBank : 16) / Drug target genes : 17 - Drug target pathways : 106
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|